• OUR DATA
  • BUY REPORTS & LISTS
  • OUR BLOG
 

Janssen Pharmaceuticals Inc Revenue and Financial Data

Janssen Pharmaceuticals jaunts across the drug market, offering therapeutics for mental health, neurology, pain management, infectious disease, and a number of other ailments. A US-based arm of Johnson & Johnson's global pharmaceuticals segment, the company's offerings include Risperdal for schizophrenia, anti-infective Levaquin, ADHD drug Concerta, acid reflux medication Aciphex, pain medicine Nucynta, and contraceptive Ortho Evra. Janssen Pharmaceuticals markets its products in the US through a direct sales force to doctors and pharmacies, as well as through wholesale distributors.

Financials Information for Janssen Pharmaceuticals Inc

Track this company’s financial condition.
View Company Report
Request Your Free Trial

  • Income Statement
  • Credit Rating
Income Statement
Revenue $197.5
Gross Profit $0
Operating Income $0
Net Income $0
Diluted EPS $0

Credit Rating

High
These businesses have a high projected rate of delinquency OR a high failure risk.

Need to go deeper? No problem.

  • Save time with complex financial data at your fingertips
  • Access financial statements, SEC filings, earnings estimates, and more
  • Call (866) 473-3932 to talk to a Business Information Consultant